Biodegradable Stents Market - Size, Share, Trends, and Forecast, 2022 - 2028

Biodegradable Stents Market - Size, Share, Trends, and Forecast, 2022 - 2028

Biodegradable stents are medical devices made up of bio-absorbable material such as polymer or metal used to achieve normal flow of blood or other bloodily fluids in case of clogged or narrowed vessels. The report delivers concise and clear in-depth analysis of market size and market growth under the scope product type, material type, and end users. Furthermore, report tracks the recent product launches, and trends driving the biodegradable stents market. However, report also focuses on the factors which are hindering the global biodegradable stents market growth.
Market Dynamics
Factors such as increasing product launches with biodegradable material or technologically advanced form such as completely degradable stents and increasing incidences of cardiac coronary artery disease are driving the biodegradable stents market growth. For instance, in 2016, Biotronik SE & Co. received CE approval for Magmaris, which is first clinically-proven magnesium scaffold based bioresorbable stents for the treatment of coronary artery disease. Moreover, the pipeline product are aiding to the biodegradable stents market growth over the forecast period. For instance, Scitech Produtos Medicos Ltda is conducting clinical trials for Inspiron stents and biomatrix flex stents for the coronary artery disease, which as on April 2018, was in phase 4 trial. However, the drawbacks associated with polymer such as expansion and recoiling of stents, are expected to restrain the biodegradable stents market growth.
Key features of the study:

This report provides in-depth analysis of the biodegradable stents market and its application, market size (US$ Million) and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global biodegradable stents market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Boston Scientific Corporation, Abbott, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc. and Arterial Remodeling Technologies SA
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion and marketing tactics.
The global biodegradable stents market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of biodegradable stents, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the biodegradable stents market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

Global Biodegradable Stents Market, By Product Type:

Coronary Stents
Peripheral Stents

Global Biodegradable Stents Market, By Material Type:

Polymer-based Stents
Metallic Stents

Global Biodegradable Stents Market, By End Users:

Hospitals
Specialty Clinics
Ambulatory Surgical Centers

Global Biodegradable Stents Market, By Region:

North America

By Product Type:

Coronary Stents
Peripheral Stents

By Material Type:

Polymer-based Stents
Metallic Stents

By End Users:

Hospitals
Specialty Clinics
Ambulatory Surgical Centers

By Country:

U.S.
Canada

Latin America

By Product Type:

Coronary Stents
Peripheral Stents

By Material Type:

Polymer-based Stents
Metallic Stents

By End Users:

Hospitals
Specialty Clinics
Ambulatory Surgical Centers

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

Europe

By Product Type:

Coronary Stents
Peripheral Stents

By Material Type:

Polymer-based Stents
Metallic Stents

By End Users:

Hospitals
Specialty Clinics
Ambulatory Surgical Centers

By Country:

Germany
U.K.
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

By Product Type:

Coronary Stents
Peripheral Stents

By Material Type:

Polymer-based Stents
Metallic Stents

By End Users:

Hospitals
Specialty Clinics
Ambulatory Surgical Centers

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Middle East

By Product Type:

Coronary Stents
Peripheral Stents

By Material Type:

Polymer-based Stents
Metallic Stents

By End Users:

Hospitals
Specialty Clinics
Ambulatory Surgical Centers

By Country:

GCC
Israel
Rest of Middle East

Africa

By Product Type:

Coronary Stents
Peripheral Stents

By Material Type:

Polymer-based Stents
Metallic Stents

By End Users:

Hospitals
Specialty Clinics
Ambulatory Surgical Centers

By Country:

North Africa
Central Africa
South Africa

Company Profiles

Boston Scientific Corporation*

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies

Abbott
Kyoto Medical Planning Co., Ltd.
QualiMed
Elixir Medical Corporation
ENDOCOR GmbH
BIOTRONIK SE & Co. KG
Amaranth Medical, Inc.
Arterial Remodeling Technologies SA

“*” marked represents similar segmentation in other categories in the respective section.